Synnovia playing catch-up
Synnnovia PLC (LON:SYN) has released a trading update for the year to 31 March. The company continues to expect significant growth in revenue and profits, with progress remaining strong in the higher margin Industrial division.
However, profitability for the group as a whole will now be below previous expectations. Previously reported delays in new projects in the Films division were resolved as expected, but the catch-up during January-March has not been strong enough to offset the impacts on profits. Also within Films, there have been some cost escalations affecting profitability for the division.
The company has also announced that it will publish some revisions to previously reported revenues, with the adjustments being described as "non-material".
We are now forecasting revenue growth of 7% and earnings per share (EPS) growth of 2% for the full year (FY) to March 2019. Our new forecasts are below our previous forecasts by 2.4% at the revenue level and 7% at the EPS level.
For FY March 2020 we are lowering our EPS forecast by 12% but are still forecasting 18.6% EPS growth versus FY March 2019. Our new forecast assumes 1) delays in Films are resolved, 2) growth in both divisions, 3) growth will be partially offset by the cost escalations in Films.
We are forecasting revenue growth of 9.7% and EPS growth of 18.6% for FY March 2020. This reflects the benefit of growth investments in recent years and improving underlying earnings (EBITDA) margins. We outline the drivers of EBITDA margins on p2 of this report.
The shares are now trading on a FY March 2020e price/earnings (P/E) multiple of 7.4x. We believe that this discount multiple reflects market concerns about the issues that have affected Films. We expect to see a material positive re-rating if the company can demonstrate steady progress towards market expectations during FY Mar 2020.
Quick facts: Synnovia PLC
Price: 125 GBX
Market Cap: £48.74 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Synnovia PLC named herein, including the promotion by the Company of Synnovia PLC in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE
LEGAL NOTICE – IMPORTANT – PLEASE READ:
Proactive Research is a trading name of Proactive Investors Limited which is regulated and authorised by the Financial Conduct Authority (FCA) under firm registration...FOR OUR FULL DISCLAIMER CLICK HERE